Polymorphisms in the Interferon Regulatory Factor-1 Promoter Are Not Associated with Psoriasis and Do Not Influence IFN-α-Induced Th1 Polarization
- 1 October 2007
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Interferon & Cytokine Research
- Vol. 27 (10), 841-846
- https://doi.org/10.1089/jir.2007.0013
Abstract
Psoriasis is a chronic inflammatory skin disease, characterized by a Th1 cytokine profile. We previously demonstrated that type I interferon (IFN-α/β) signaling is activated in psoriatic skin. Type I IFNs regulate the expression of many proinflammatory and anti-inflammatory cytokines, resulting in Th1 polarization. We assessed whether peripheral blood mononuclear cells (PBMC) from psoriatic patients show aberrant IFN-α responses. IFN-α stimulation caused a similar enhancement of IFN-γ and interleukin-10 (IL-10) secretion in psoriasis patients and controls, although the level of induction was variable. It was previously suggested that IFN-α-induced Th1 polarization is influenced by single nucleotide polymorphisms (SNPs) in the promoter of IFN regulatory factor-1 (IRF-1), a transcription factor involved in IFN signaling, providing a putative explanation for the observed variation. However, sequence analysis revealed no correlation between SNPs in the IRF-1 promoter and induction of IFN-γ or IL-10 expression. Furthermore, the frequency of the SNPs and psoriasis were not linked. Our data demonstrate that the described IRF-1 promoter SNPs do not play a role in the pathogenesis of psoriasis or in influencing IFN-α-induced Th1 polarization. We further demonstrate that psoriatic PBMCs do not respond aberrantly to IFN-α with respect to the production of the proinflammatory IFN-γ and the anti-inflammatory IL-10.Keywords
This publication has 30 references indexed in Scilit:
- Plasmacytoid predendritic cells initiate psoriasis through interferon-α productionThe Journal of Experimental Medicine, 2005
- Contribution of Irf-1 promoter polymorphisms to the Th1-type cell response and interferon-β monotherapy for chronic hepatitis CHepatology Research, 2005
- Novel interferon regulatory factor-1 polymorphisms in a Kenyan population revealed by complete gene sequencingJournal of Human Genetics, 2004
- Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-αThe Journal of Experimental Medicine, 2004
- In Psoriasis Lesional Skin the Type I Interferon Signaling Pathway Is Activated, Whereas Interferon-α Sensitivity Is UnalteredJournal of Investigative Dermatology, 2004
- The International Psoriasis Genetics Study: Assessing Linkage to 14 Candidate Susceptibility Loci in a Cohort of 942 Affected Sib PairsAmerican Journal of Human Genetics, 2003
- The Detection of IRF-1 Promoter Polymorphisms and Their Possible Contribution to T Helper 1 Response in Chronic Hepatitis CJournal of Interferon & Cytokine Research, 2002
- Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritisArthritis & Rheumatism, 2001
- Lack of association between the interferon regulatory factor-1 (IRF1) locus at 5q31.1 and multiple sclerosis in Germany, Northern Italy, Sardinia and SwedenGenes & Immunity, 2000
- NO ASSOCIATION OR LINKAGE TO IDDM OF AN INTERFERON REGULATORY FACTOR-1 GENE POLYMORPHISM IN A DANISH POPULATIONEuropean Journal of Immunogenetics, 1997